InvestorsHub Logo

Andy2018

07/24/20 9:09 PM

#98157 RE: Whosonfirst #98151

Exactly at 19:00 mark it seems Leronlimab only there is no other therapy drug close to approval in all mild to moderate and severe. Leronlimab is the only drug unblinding (phase 2 & 3)the data currently since last week.